Martinostat
Martinostat is an experimental drug candidate that is being studied for its potential use in the treatment of various diseases. It is a small molecule inhibitor of histone deacetylases (HDACs), a group of enzymes that play a key role in the regulation of gene expression. Martinostat has been shown to have potent activity against HDACs, and it is thought that it may have potential therapeutic applications in diseases where these enzymes are dysregulated, such as cancer and neurological disorders.
Mechanism of Action[edit | edit source]
Martinostat works by inhibiting the activity of HDACs. These enzymes are responsible for removing acetyl groups from histones, which are proteins that help package DNA into a compact, organized structure within the cell nucleus. By inhibiting HDACs, Martinostat can increase the acetylation of histones, leading to changes in the structure of the chromatin and the regulation of gene expression. This can potentially affect the growth and survival of cells, making Martinostat a potential therapeutic agent for diseases characterized by abnormal cell growth and survival, such as cancer.
Clinical Development[edit | edit source]
Martinostat is currently in the early stages of clinical development. Preclinical studies have shown that it has potent activity against HDACs and can induce changes in gene expression that are associated with cell growth and survival. However, further studies are needed to determine the safety and efficacy of Martinostat in humans.
Potential Applications[edit | edit source]
Given its mechanism of action, Martinostat may have potential applications in a variety of diseases where HDACs are dysregulated. This includes various types of cancer, as well as neurological disorders such as Huntington's disease and Alzheimer's disease. However, more research is needed to fully understand the potential therapeutic applications of Martinostat.
See Also[edit | edit source]
References[edit | edit source]
| Martinostat Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
